Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Endocrinology

The Diagnostic Process: Finding the Ectopic Source

At a Glance

Finding an ectopic aldosterone-producing tumor usually requires confirming excess aldosterone with an aldosterone-renin ratio and suppression testing, then using adrenal venous sampling, specialized PET/CT, or targeted venous sampling when routine CT or MRI is normal.

Finding an ectopic aldosterone-producing tumor (EAPT) is often a complex localization process. Because these tumors hide outside the usual location of the adrenal glands, doctors must use a specific sequence of tests to first confirm that excess aldosterone is being produced and then hunt down its exact hiding spot.

The First Clue: The ARR Screen

The journey typically begins with a blood test called the Aldosterone-to-Renin Ratio (ARR) [1]. This test measures the balance between aldosterone (the salt-retaining hormone) and renin (the enzyme that usually triggers aldosterone production). In primary aldosteronism, your aldosterone will be high while your renin is “suppressed” or very low [2].

However, this test is highly sensitive to your internal environment. Two factors must be managed before the test:

  • Potassium Correction: If your potassium is low, your body may naturally suppress aldosterone production, which can lead to a “false negative” result. Your doctor will likely ensure your potassium is in the normal range before drawing blood [3].
  • Medication Management: Many common blood pressure medications, such as spironolactone, ACE inhibitors, or beta-blockers, can interfere with renin and aldosterone levels. Never stop or change your medications without your prescriber’s explicit plan. Your clinical team will balance test accuracy against blood-pressure safety, sometimes transitioning you to “neutral” medications under close supervision before the test to ensure the results are accurate [1][4].

Confirming the Diagnosis

If your ARR is high, the next step is often a suppression test to prove the aldosterone production is truly autonomous and not just a temporary reaction. Common methods include:

  • Saline Infusion Test: You receive a large amount of salt water through an IV. In a healthy person, this salt load should signal the body to stop making aldosterone. However, this test is specialist-guided and may be unsafe for individuals with severe hypertension, heart failure, or kidney disease. If your levels stay high, the diagnosis is confirmed [5].
  • Captopril Challenge: You take a dose of a medication called captopril, and your blood is tested two hours later to see if aldosterone levels drop as expected [6].

Locating the Source

Once the condition is confirmed, the challenge is finding the tumor. While a standard CT scan or MRI of the abdomen is the first step, these scans often show “normal” adrenal glands in patients with an ectopic tumor [7][8].

Adrenal Venous Sampling (AVS)

AVS is the “gold standard” for determining which side of the body is producing the hormone [7]. An interventional radiologist threads a tiny catheter into the veins draining the adrenal glands to evaluate if secretion is lateralized to one adrenal gland. Its interpretation depends on successful catheterization.

In a typical case, one adrenal vein shows very high levels while the other is low. However, in an ectopic case, doctors may see discordant results (where the scan says one thing and the AVS says another) or bilateral suppression [9][10]. Bilateral suppression means the aldosterone levels in both adrenal veins are lower than the levels in the rest of your bloodstream. Bilateral suppression can raise suspicion for an ectopic source, but it can also reflect technical sampling problems or medication effects, so it is not absolute proof [10][11].

Advanced Functional Imaging

When AVS suggests the source is ectopic, specialized functional imaging may be used to find it. These scans use “tracers” that target the enzymes or receptors involved in making aldosterone:

  • 11C-metomidate PET/CT: This tracer binds to the enzymes (including CYP11B1 and CYP11B2) that produce aldosterone, making the tumor “glow” on the scan. However, it has limited availability and interpretive limitations [12][13].
  • 68Ga-Pentixafor PET/CT: This newer scan targets a specific receptor (CXCR4) that is often highly present in aldosterone-producing tissue, though this is a highly specialized or investigational approach [14][15].

Segmental and Systemic Venous Sampling

If a suspicious spot is found on a PET scan—for example, in the liver or near the pancreas—doctors may perform segmental venous sampling. This involves taking blood samples from the specific small veins draining that exact area to evaluate it as the source before proceeding to surgery [16][17]. This highly specialized procedure cannot always prove causation, but helps map the tissue.

Common questions in this guide

What does a high aldosterone-renin ratio tell me?
A high aldosterone-renin ratio, or ARR, can raise concern for primary aldosteronism, especially when aldosterone is high and renin is suppressed. It does not by itself prove that an ectopic tumor is present. Low potassium and some blood-pressure medicines can change the result, so the test must be interpreted with careful preparation.
Why do potassium levels and medicines matter before the hormone test?
Low potassium can suppress aldosterone and make the ARR falsely reassuring. Spironolactone, ACE inhibitors, beta-blockers, and other medicines can alter renin or aldosterone. Never stop or change a medicine on your own; your prescriber should create a safe plan.
What happens if my CT or MRI does not show an adrenal tumor?
Normal-looking adrenal glands do not exclude an ectopic aldosterone-producing tumor. Doctors may review adrenal venous sampling and use specialized functional imaging, such as 11C-metomidate or 68Ga-Pentixafor PET/CT, to search outside the adrenal glands. If a suspicious site is found, targeted venous sampling may help assess it.
What can adrenal venous sampling show?
Adrenal venous sampling compares aldosterone levels in blood from the veins draining each adrenal gland with levels in the wider bloodstream. Discordant results or low levels from both adrenal veins may raise suspicion for an ectopic source. These patterns can also result from catheter-placement problems or medication effects, so they are not absolute proof.
How do functional PET scans help locate an ectopic tumor?
11C-metomidate PET/CT targets enzymes involved in aldosterone production, while 68Ga-Pentixafor PET/CT targets CXCR4 in aldosterone-producing tissue. These scans are specialized, may not be widely available, and can have interpretation limits. A scan finding may need confirmation with other tests.
Why might doctors sample veins near the liver or pancreas?
If imaging shows a suspicious spot in or near an organ, segmental venous sampling collects blood from smaller veins draining that area. A higher aldosterone level can help map where the hormone is coming from before surgery. The procedure may guide localization but cannot always prove that the sampled tissue caused the hormone excess.

Get notified when new evidence is published on Ectopic aldosterone-producing tumor.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Taiwan mini-frontier of primary aldosteronism: Updating detection and diagnosis.

    Chang CC, Chen YY, Lai TS, et al.

    Journal of the Formosan Medical Association = Taiwan yi zhi 2021; (120(1 Pt 1)):121-129 doi:10.1016/j.jfma.2020.08.001.

    PMID: 32855034
  2. 2

    Evaluation and Management of Primary Aldosteronism.

    Parisien-La Salle S, Vaidya A

    Endocrinology and metabolism clinics of North America 2026; (55(2)):271-284 doi:10.1016/j.ecl.2025.12.002.

    PMID: 42067270
  3. 3

    International multicenter survey on screening and confirmatory testing in primary aldosteronism.

    Naruse M, Murakami M, Katabami T, et al.

    European journal of endocrinology 2023; (188(1)) doi:10.1093/ejendo/lvac002.

    PMID: 36726325
  4. 4

    Primary Hyperaldosteronism: Epidemiology, Diagnosis, and Clinical Associations.

    Savvidis C, Milionis C, Pachi A, et al.

    Epidemiologia (Basel, Switzerland) 2026; (7(2)) doi:10.3390/epidemiologia7020032.

    PMID: 41873981
  5. 5

    Confirmatory Tests for the Diagnosis of Primary Aldosteronism: A Prospective Diagnostic Accuracy Study.

    Song Y, Yang S, He W, et al.

    Hypertension (Dallas, Tex. : 1979) 2018; (71(1)):118-124 doi:10.1161/HYPERTENSIONAHA.117.10197.

    PMID: 29158354
  6. 6

    The diagnostic utility of the captopril challenge test for primary aldosteronism in a Bangladeshi population: a prospective study.

    Jahan S, Lu ZX, Akram M, et al.

    Pathology 2025; (57(7)):917-924 doi:10.1016/j.pathol.2025.04.003.

    PMID: 40615326
  7. 7

    The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

    Funder JW, Carey RM, Mantero F, et al.

    The Journal of clinical endocrinology and metabolism 2016; (101(5)):1889-916 doi:10.1210/jc.2015-4061.

    PMID: 26934393
  8. 8

    Morphologically Normal-Appearing Adrenal Glands as a Prevalent Source of Aldosterone Production in Primary Aldosteronism.

    Parksook WW, Yozamp N, Hundemer GL, et al.

    American journal of hypertension 2022; (35(6)):561-571 doi:10.1093/ajh/hpab189.

    PMID: 34883509
  9. 9

    "Double-Down" Adrenal Vein Sampling Results in Patients with Apparent Bilateral Aldosterone Suppression: Utility of Repeat Sampling including Super-Selective Sampling.

    DePietro DM, Fraker DL, Wachtel H, et al.

    Journal of vascular and interventional radiology : JVIR 2021; (32(5)):656-665 doi:10.1016/j.jvir.2020.12.029.

    PMID: 33781686
  10. 10

    Duplicated adrenal veins in primary aldosteronism misdiagnosed with ectopic aldosteronoma due to apparent bilateral aldosterone suppression.

    Yu J, Fan C, Wei W, et al.

    Blood pressure 2023; (32(1)):2209664 doi:10.1080/08037051.2023.2209664.

    PMID: 37183447
  11. 11

    Case Report: Anomalous drainage vein sampling for diagnosing aldosterone-producing lesions undetectable by segmental adrenal venous sampling in a two-case series.

    Tannai H, Oguro S, Kamada H, et al.

    Frontiers in radiology 2025; (5()):1567779 doi:10.3389/fradi.2025.1567779.

    PMID: 40557128
  12. 12

    11C-metomidate PET in the diagnosis of adrenal masses and primary aldosteronism: a review of the literature.

    Chen Cardenas SM, Santhanam P

    Endocrine 2020; (70(3)):479-487 doi:10.1007/s12020-020-02474-3.

    PMID: 32886316
  13. 13

    Molecular Imaging Versus Adrenal Vein Sampling for the Detection of Surgically Curable Primary Aldosteronism : A Prospective Within-Patient Trial.

    Goodchild E, Wu X, Senanayake R, et al.

    Annals of internal medicine 2025; (178(3)):336-347 doi:10.7326/ANNALS-24-00761.

    PMID: 40030172
  14. 14

    Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma.

    Heinze B, Fuss CT, Mulatero P, et al.

    Hypertension (Dallas, Tex. : 1979) 2018; (71(2)):317-325 doi:10.1161/HYPERTENSIONAHA.117.09975.

    PMID: 29279316
  15. 15

    Clinical value of CXCR4-targeted PET-CT in primary aldosteronism: a systematic review and meta-analysis.

    Tang R, Pu J, Huang Z

    European journal of nuclear medicine and molecular imaging 2025; (52(12)):4706-4716 doi:10.1007/s00259-025-07312-0.

    PMID: 40304781
  16. 16

    Intra-adrenal Aldosterone Secretion: Segmental Adrenal Venous Sampling for Localization.

    Satani N, Ota H, Seiji K, et al.

    Radiology 2016; (278(1)):265-74 doi:10.1148/radiol.2015142159.

    PMID: 26147784
  17. 17

    An unexpected finding of apparent bilateral aldosterone suppression after superselective adrenal venous sampling: a case report.

    Pan X, Ma Y, Kang Y, et al.

    Blood pressure 2026; (35(1)):2678033 doi:10.1080/08037051.2026.2678033.

    PMID: 42165404

This page explains how clinicians investigate an ectopic aldosterone-producing tumor for informational purposes only and does not constitute medical advice. Do not change blood-pressure medicines or pursue testing without guidance from your treating team.